# Evaluating the Impact of Different Methods of HPV DNA Testing for Cervical Cancer Screening in Primary Care Settings

> **NCT06528184** · NA · RECRUITING · sponsor: **National Healthcare Group Polyclinics** · enrollment: 650 (estimated)

## Conditions studied

- Uterine Cervical Neoplasms

## Interventions

- **DIAGNOSTIC_TEST:** Self-sampled HPV DNA testing
- **DIAGNOSTIC_TEST:** Clinician-sampled HPV DNA test

## Key facts

- **NCT ID:** NCT06528184
- **Lead sponsor:** National Healthcare Group Polyclinics
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-05
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 650 (ESTIMATED)
- **Last updated:** 2025-02-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06528184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06528184, "Evaluating the Impact of Different Methods of HPV DNA Testing for Cervical Cancer Screening in Primary Care Settings". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06528184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*